AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Macsita-M 50/500 Tablet

Prescription Icon
Prescription Required

Marketer

Macleods Pharmaceuticals Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Macsita-M 50/500 Tablet

Diabetics with type 2 mellitus can manage their elevated blood glucose with Glycemia-Duo 50/500, a dual-action tablet. This combination therapy mitigates serious diabetic complications like renal impairment and vision loss, potentially lowering cardiovascular event risk. Glycemia-Duo 50/500 may be a standalone treatment or complement existing diabetes medication, ideally coupled with a balanced diet and regular physical activity. Dosage is individualized, considering your health status, glucose levels, and other concurrent medications. Consuming it with food minimizes gastrointestinal distress. Consistent daily dosing, as prescribed, maximizes efficacy; discontinue only under medical guidance. Adherence to your physician's dietary and exercise plan is crucial for effective diabetes control; lifestyle choices are integral to management. Common side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential risk, especially with concomitant insulin or sulfonylurea use; learn its symptoms and management. This medication isn't universally suitable. Inform your doctor of any pre-existing kidney, liver, heart, or pancreatic conditions, or significant alcohol consumption before initiating treatment. Pregnant or lactating individuals should seek medical counsel prior to use. Potential drug interactions exist; disclose all medications to your physician to ensure safety. Alcohol should be minimized due to its hypoglycemic effect. Regular monitoring of renal function and blood glucose levels will be performed by your doctor throughout treatment.

Uses of Macsita-M 50/500 Tablet

Managing type 2 diabetes

Major Benefits of Macsita-M 50/500 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take the Macsita-M 50/500 Tablet with a meal.

Common Side effects of Macsita-M 50/500 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Macsita-M 50/500 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Macsita-M 50/500 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

How Macsita-M 50/500 Tablet works:

Macsita-M 50/500 tablets combine sitagliptin and metformin to manage blood sugar. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, decreases liver glucose production, slows intestinal glucose absorption, and boosts insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Macsita-M 50/500 Tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Macsita-M 50/500 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Macsita-M 50/500 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Macsita-M 50/500 Tablets, potentially requiring dosage modification. Consult a physician before use. Macsita-M 50/500 Tablets are contraindicated in individuals with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverUNSAFE

Individuals with liver impairment should likely refrain from using Macsita-M 50/500 Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Macsita-M 50/500 Tablet :

Should you forget a dose of Macsita-M 50/500 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Macsita-M 50/500 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Macsita-M 50/500 Tablet

Macsita-M 50/500 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Macsita-M 50/500 tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), and urinary issues, along with cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Macsita-M 50/500 Tablet may cause common side effects including hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
Macsita-M 50/500 Tablet is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Macsita-M 50/500 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Macsita-M 50/500 (containing metformin) can cause lactic acidosis (MALA), a serious medical emergency characterized by high blood lactic acid levels. This rare side effect necessitates avoiding metformin use in patients with kidney disease, the elderly, or heavy alcohol consumers. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea/vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Macsita-M 50/500 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Macsita-M 50/500 Tablet may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Macsita-M 50/500 Tablet is contraindicated in patients with known allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Macsita-M 50/500 tablets with alcohol is unsafe and may raise your risk of lactic acidosis.
Macsita-M 50/500 (containing metformin) can cause lactic acidosis (MALA), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates caution in patients with kidney disease, the elderly, or those consuming large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Macsita-M 50/500 tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Macsita-M 50/500 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Macsita-M 50/500 Tablet may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Macsita-M 50/500 Tablet is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Macsita-M 50/500 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Macsita-M 50/500 (containing metformin) can cause lactic acidosis (MALA), a serious medical emergency involving high blood lactic acid levels. This rare side effect necessitates caution in patients with kidney disease, older adults, or those consuming excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Macsita-M 50/500 tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate these risks, annual supplemental vitamin B12 intake is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Macsita-M 50/500 Tablet
114